Zobrazeno 1 - 10
of 93
pro vyhledávání: '"J, Meharchand"'
Autor:
Khalil Sivjee, J Meharchand, Max Dahele, Yee Ung, Corey Weigensberg, Harry Shulman, Robert Zeldin, Abdollah Behzadi, Susanna Cheng, Carmine Simone
Publikováno v:
Current Oncology
Volume 14
Issue 6
Pages 157-237
Volume 14
Issue 6
Pages 157-237
Lung cancer is the leading cause of cancer death in Canada. The organization of health care services is central to the delivery of accessible, high-quality medical care and may be one factor that influences patient outcome. An exciting opportunity ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec6a706666630fadd4001774e58138a
https://doi.org/10.3747/co.2007.157
https://doi.org/10.3747/co.2007.157
Autor:
J Meharchand, A. Benger, Hans A. Messner, S Jamal, Lothar Huebsch, Irwin Walker, A Smith, Armand Keating, S Gluck, Aaron D. Schimmer
Publikováno v:
Bone Marrow Transplantation. 26:859-864
In 1986, the bone marrow transplant centers in Ontario agreed to a strategy for the treatment of patients with NHL. Suitable patients would undergo autotransplant but be referred for allotransplant if they had persistent marrow involvement or an inad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a60f8513264cdd5cc5b251a2361404e3
https://doi.org/10.1038/sj.bmt.1702625
https://doi.org/10.1038/sj.bmt.1702625
Autor:
T Tasev, E Pinchefsky, Tony Panzarella, L Shulman, N Boyce, N Blanchette, S Poon, B. Patterson, P. H. Pinkerton, Graham D. Sher, W Lau, D Greenspan, V Blanchette, Barbara Hannach, P MacK, K Thomas, J Pinchefsky, Jane E. Freedman, J Meharchand
Publikováno v:
Transfusion Medicine. 10:199-206
Platelet transfusion reactions were prospectively studied in haematology/oncology patients at five university teaching hospitals over three consecutive summers. The initial summer study provided baseline information on the use of premedications and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5043388e1160df5a1cf22f811036ba1
https://doi.org/10.1046/j.1365-3148.2000.00253.x
https://doi.org/10.1046/j.1365-3148.2000.00253.x
Autor:
JH Lipton, Tony Mazzulli, H.A. Messner, Vijay Reddy, Charles K. Chan, M. Minden, Y. Hao, J Meharchand
Publikováno v:
Journal of Clinical Virology. 13:149-159
Background: Patients undergoing allogeneic bone marrow transplant (BMT) are considered to be at increased risk of cytomegalovirus (CMV) disease if they and/or their donor are CMV seropositive pre-transplant. Although several pre-emptive strategies ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79909b64c3bd56a6544240a0f3dfaa44
https://doi.org/10.1016/s1386-6532(99)00029-3
https://doi.org/10.1016/s1386-6532(99)00029-3
Autor:
Keith O'Rourke, Tony Mazzulli, Parveen Wasi, J Meharchand, Jeffrey H. Lipton, Allison McGeer, Hans A. Messner, Atul Humar, James B. Mahony, George Moussa, Irwin Walker, R Chua
Publikováno v:
Bone Marrow Transplantation. 23:45-51
At our institution, the cytomegalovirus (CMV) prophylaxis protocol for allogeneic bone marrow transplant (BMT) recipients who are CMV-seropositive or receive marrow from a CMV-seropositive donor consists of a surveillance bronchoscopy approximately 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78e472acae1e31bc7773bfa4ac9ce7a
https://doi.org/10.1038/sj.bmt.1701525
https://doi.org/10.1038/sj.bmt.1701525
Autor:
L Tinker, Hans A. Messner, P Andreou, J Meharchand, Ronan Foley, G. Dranitsaris, David Spaner, S Jamal, N Jamal, Jeffrey H. Lipton, Irwin Walker, S Price, Stephen Couban
Publikováno v:
Bone Marrow Transplantation. 22:1199-1205
Allogeneic peripheral blood progenitor cell (PBPC) transplants are an alternative to BMT, although G-CSF mobilization dose, timing of pheresis and risk of GVHD are not well defined. We compared harvest characteristics, donor and recipient outcomes an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06edd28ffb1eaf243f03798f3c132ecf
https://doi.org/10.1038/sj.bmt.1701504
https://doi.org/10.1038/sj.bmt.1701504
Autor:
A K Stewart, Aaron D. Schimmer, Michael Crump, D M Sutton, Frances A. Shepherd, J Meharchand, Armand Keating, J MacKinnon
Publikováno v:
Bone Marrow Transplantation. 22:491-494
The use of autologous stem cell transplantation (ASCT) for the treatment of multiple myeloma is increasing. Anticoagulation may be required during ASCT for conditions such as Hickman line thrombosis. The safety of anticoagulation in patients receivin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79df705e7994b2c69994e0077a7b32cb
https://doi.org/10.1038/sj.bmt.1701363
https://doi.org/10.1038/sj.bmt.1701363
Publikováno v:
Bone Marrow Transplantation. 19:783-789
We report the results of a consecutive series of patients who underwent autologous (auto) (40), allogeneic (allo) (22) or syngeneic transplantation (2) for multiple myeloma (MM) at our centre. Median age at diagnosis was 45.5 (auto) and 43 (allo) yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1289316b7b83750f0f636ebd33698a2
https://doi.org/10.1038/sj.bmt.1700738
https://doi.org/10.1038/sj.bmt.1700738
Autor:
Cassian Yee, H. A. Messner, Hong Chang, L. Addy, Mark D. Minden, Xing-Hua Wang, J. Meharchand
Publikováno v:
Journal of Clinical Investigation. 89:1014-1020
The development of a cell culture system efficient in the establishment of lymphoma cell lines has made it possible to dissect basic biological and molecular aspects of lymphoma cells. We have established a lymphoma cell line from a patient with B ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5b54698687773e4eb8558f4103084a
https://doi.org/10.1172/jci115642
https://doi.org/10.1172/jci115642
Autor:
Mark D. Minden, Dean Chamberlain, Charles K. Chan, Joseph Chien, B. Patterson, Hans A. Messner, J Meharchand, Gillian Fyles
Publikováno v:
Chest. 98:1034-1037
Recent literature suggests that CMV pneumonia is an immunopathologic process. This case report summarizes the clinical course of a patient which supports this hypothesis. The patient is the recipient of an allogeneic BMT who recovered from an episode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5507420448972d5d292416f49fde3032
https://doi.org/10.1378/chest.98.4.1034
https://doi.org/10.1378/chest.98.4.1034